Literature DB >> 7686337

Maternal serum screening for alpha-fetoprotein, unconjugated estriol, and human chorionic gonadotropin between 11 and 15 weeks of pregnancy to detect fetal chromosome abnormalities.

B F Crandall1, F W Hanson, S Keener, M Matsumoto, W Miller.   

Abstract

OBJECTIVE: The purpose of this prospective study was to assess the value of maternal serum screening between 11 and 15 weeks of gestation to detect fetal Down syndrome. STUDY
DESIGN: Blood samples were collected on 993 women between 11 and 15 weeks' gestation before amniocentesis. Ninety percent were > or = 35 years old. Samples were coded and assayed for alpha-fetoprotein, unconjugated estriol, and human chorionic gonadotropin. Medians were established at each week between 11 and 15 from 836 normal, singleton pregnancies.
RESULTS: We used a computer-generated cut-off risk for Down syndrome of one in 365 at term; nine of 11 (82%) Down syndrome pregnancies were identified. There were 23% false-positive results in women > or = 35 years old and 6% in those < 35 years.
CONCLUSION: These results suggest that maternal serum screening between 11 and 15 weeks may provide an acceptable alternative to screening between 16 and 20 weeks.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7686337     DOI: 10.1016/0002-9378(93)90703-l

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  4 in total

1.  Prenatal diagnosis and fetal therapy--what lies in future?

Authors:  J Mauldin
Journal:  Indian J Pediatr       Date:  2000-12       Impact factor: 1.967

Review 2.  Down's syndrome screening: a controversial test, with more controversy to come!

Authors:  T M Reynolds
Journal:  J Clin Pathol       Date:  2000-12       Impact factor: 3.411

3.  DASAF: An R Package for Deep Sequencing-Based Detection of Fetal Autosomal Abnormalities from Maternal Cell-Free DNA.

Authors:  Baohong Liu; Xiaoyan Tang; Feng Qiu; Chunmei Tao; Junhui Gao; Mengmeng Ma; Tingyan Zhong; JianPing Cai; Yixue Li; Guohui Ding
Journal:  Biomed Res Int       Date:  2016-06-29       Impact factor: 3.411

Review 4.  First trimester serum tests for Down's syndrome screening.

Authors:  S Kate Alldred; Yemisi Takwoingi; Boliang Guo; Mary Pennant; Jonathan J Deeks; James P Neilson; Zarko Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2015-11-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.